AzTrials
AzTrials

Lateral EpicondylitisNCT06342518

ESWT in Lateral Epicondylitis: Clinical,Ultrasonographic Evaluation

A study testing Extracorporeal Shock Wave Therapy (ESWT) and Resting Splint , Exercises and ice in people with Lateral Epicondylitis and Tennis Elbow, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to check and compare how well shock wave therapy works for tennis elbow, both in terms of symptoms and what we can see on ultrasound. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Lateral Epicondylitis, Tennis Elbow
What is being tested?
Extracorporeal Shock Wave Therapy (ESWT) and Resting Splint , Exercises and ice
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Dec 2020to 1 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • experiencing pain and tenderness in the lateral epicondyle while extending their wrist and fingers against resistance for at least 3 months

Who cannot join

  • Patients who are pregnant or have a coagulation disorder, cervical radiculopathy, peripheral neuropathy, peripheral vasculopathy in the upper extremity, complex regional pain syndrome, local infections, systemic inflammatory disease, fibromyalgia syndrome, arthritis (including rheumatoid arthritis, spondylarthritis, and crystal-induced arthropathies), malignancy, or those who have been treated with corticosteroids, PRP, or autologous blood injection, as well as those who have received physical therapy agents, undergone upper-extremity surgical interventions, or have a history of direct trauma to the elbow or a history of fracture,

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Medeniyet University Faculty of Medicine, Physical Medicine and Rehabilitation Department

    Istanbul, 34732

Other trials in Turkey (Türkiye)

About this study

Official title: Clinical and Sonographic Evaluation of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) in Patients With Lateral Epicondylitis

This study aimed to check and compare how well shock wave therapy works for tennis elbow, both in terms of symptoms and what we can see on ultrasound.

Read the detailed description

42 patients with tennis elbow were split into two groups by chance: one group received shock wave therapy (ESWT), while the other received a fake treatment (Sham-ESWT) for comparison. Both groups underwent wrist exercises, splint usage, and ice application. Grip strength, pain levels, and how well they could move their wrist (functionality) were measured before, after, and one month post-treatment using tests. Additionally, the thickness of a common extensor tendon (CET) was evaluated using ultrasound. The patient, the doctor checking the patient, and the doctor doing the ultrasound didn't know which group the patient was in.

Being tested
Extracorporeal Shock Wave Therapy (ESWT), Sham ESWT, Resting Splint , Exercises and ice
Keywords
Extracorporeal Shock Wave Therapy (ESWT), sonographic assessment, Lateral epicondylitis
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extracorporeal Shock Wave Therapy (ESWT)Device

    The ESWT group received radial ESWT each session with a total of 2000 pulses at a frequency of 10 Hz. A gel was used at the interface, and the air pressure was set at 1.8 bar per session.

  • Sham ESWTDevice

    The Sham-ESWT group received Sham radial ESWT each session, but without actual contact of the applicator. To enhance the illusion of treatment, gel was applied, and the device emitted sound at every shock

  • Resting Splint , Exercises and iceBehavioural

    Ensuring proper usage of the wrist resting splint by the patient was confirmed during follow-up visits. The physician instructed the patients on stretching and strengthening exercises for wrist extensors, which they were asked to perform three times a day. Application of ice for 20 minutes every 3-4 hours during painful periods was recommended. During follow-up visits patients confirmed that they adherence to exercises and recommendations.

Study groups in NCT06342518
Study groupRoleWhat they receive
ESWT GROUPExperimentalThe ESWT group received radial ESWT on the painful lateral epicondyle once per week for a total of 3 sessions. A wrist resting splint, wrist extensor strengthening and stretching exercises, and ice treatment were administered to both groups.
Receives: Device: Extracorporeal Shock Wave Therapy (ESWT); Behavioral: Resting Splint , Exercises and ice
Sham-ESWT groupSham comparatorThe Sham-ESWT group received Sham radial ESWT on the painful lateral epicondyle once per week for a total of 3 sessions. A wrist resting splint, wrist extensor strengthening and stretching exercises, and ice treatment were administered to both groups.
Receives: Device: Sham ESWT; Behavioral: Resting Splint , Exercises and ice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hand Grip Strength

    measured using the Jamar hand dynamometer

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

  2. Pain severity

    Visual Analog Scale (VAS) which was scored from 0 (no pain) to 10 (extremely severe).

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

  3. Functionality

    the Patient-Rated Tennis Elbow Evaluation (PRTEE)

    The PRTEE allows patients to rate their levels of tennis elbow pain and disability from 0 to 10, and consists of 2 subscales:

    1. PAIN subscale (0 = no pain, 10 = worst imaginable) Pain - 5 items
    2. FUNCTION subscale (0 = no difficulty, 10 = unable to do) Specific activities - 6 items Usual activities - 4 items In addition to the individual subscale scores, a total score can be computed on a scale of 100 (0 = no disability).

    Pain Score = Sum of the 5 pain items(out of 50) Best Score = 0, Worst Score =50 Function Score = Sum of the 10 function items, Divided by 2 (out of 50) Best Score = 0, Worst Score = 50

    Computing the Total Score Total Score = Sum of pain + function scores Best Score = 0, Worst Score = 50 Best Score = 0, Worst Score = 100

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

  4. Quality of life score

    Short Form-12 (SF-12), Patients are provided with the SF-12 questionnaire, which consists of 12 questions covering physical and mental health domains.

    The scoring yields two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

    PCS mean score: 56,5 MSC mean score: 60.7 Scores above mean indicate a better-than-average health-related quality of life, while scores below mean suggest below-average health.

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

  5. deep muscular tissue sensitivity

    pain pressure threshold (PPT) Pain pressure threshold (PPT) is used to measure deep muscular tissue sensitivity. The test determines the amount of pressure over a given area in which a steadily increasing nonpainful pressure stimulus turns into a painful pressure sensation. A varying pressure is applied from 0.5 to 1 kg/sec in a perpendicular direction relative to the muscle.

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

  6. thickness of the common extensor tendon (CET)

    During ultrasonography for LE, the elbow is positioned in 90 degrees of flexion and the wrist in pronation. The ultrasound probe is placed longitudinally on the radial surface of the elbow. And common extensor tendon thickness was measured sonographically.

    Measured: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2024
  2. Study start1 Dec 2020
  3. Primary completion1 Sep 2021
  4. Study completion1 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06342518
Sponsor's protocol ID
MU ESWT
Status last verified
Mar 2024
First submitted
24 Mar 2024
Last updated
2 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Extracorporeal Shock Wave Therapy (ESWT) and Resting Splint , Exercises and ice in people with Lateral Epicondylitis and Tennis Elbow, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hand Grip Strength (time frame: Baseline, post-treatment(4th week), and one-month post-treatment (8th week)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in